(+)-Alpha-Dihydrotetrabenazine Phase I

NCT02844179 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kirk A. Frey

Collaborators